Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis'
- PMID: 30131548
- PMCID: PMC6162270
- DOI: 10.1038/s41416-018-0205-8
Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis'
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis.Br J Cancer. 2018 May;118(9):1268-1275. doi: 10.1038/s41416-018-0065-2. Epub 2018 Apr 23. Br J Cancer. 2018. PMID: 29681615 Free PMC article.
References
-
- Cancer Taskforce. Achieving world-class cancer outcomes: a strategy For England 2015–2020. Cancer Research UK. (2015). https://www.cancerresearchuk.org/sites/default/files/achieving_world-cla....
-
- NICE. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Clinical Guideline CG164. (2017). https://www.nice.org.uk/guidance/cg164
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
